Allocation of retained earnings to capital investment, research and development, and the sales organization
First written in FY2016. 4 of 5 entries say "Restated". Latest entry: FY2024.
133 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「We will allocate retained earnings to capital investment, research and development investment, and expansion of the sales organization, among other purposes, and strive to enhance corporate value by strengthening our financial position and management base from a long-term perspective.」
Reconfirms the policy of allocating retained earnings to capital investment, research and development investment, and expansion of the sales organization. - FY2022RestatedAnnual report
「We will allocate retained earnings to capital investment, research and development investment, and expansion of the sales organization, among other purposes, and strive to enhance corporate value by strengthening our financial position and management base from a long-term perspective.」
Reconfirms the policy of allocating retained earnings to capital investment, research and development investment, and expansion of the sales organization. - FY2021RestatedAnnual report
「We will allocate retained earnings to capital investment, research and development investment, and expansion of the sales organization, among other purposes, and strive to enhance corporate value by strengthening our financial position and management base from a long-term perspective.」
Restates the policy of allocating retained earnings to capital investment, research and development investment, and expansion of the sales organization. - FY2017RestatedAnnual report
「We will allocate retained earnings to capital investment, research and development investment, and expansion of the sales organization, among other purposes, and strive to enhance corporate value by strengthening our financial position and management base from a long-term perspective.」
Restates the policy of allocating retained earnings to capital investment, research and development investment, and expansion of the sales organization. - FY2016First statedAnnual report
「We will allocate retained earnings to capital investment, research and development investment, and expansion of the sales organization, among other purposes, and strive to enhance corporate value by strengthening our financial position and management base from a long-term perspective.」
Policy of allocating retained earnings to capital investment, research and development investment, and expansion of the sales organization to improve the financial position, management base and corporate value.